Lifescience Advisors Limited

	Page
Statement of Financial Position	1
Notes to the Financial Statements	2—3

Registered number: 09358385

		2024		2023
	Notes	£	£	£	£
FIXED ASSETS

CURRENT ASSETS
Debtors	5	500		500
Cash at bank and in hand		29,055		28,535

		29,555		29,035
Creditors: Amounts Falling Due Within One Year	6	(46 )		(759 )

NET CURRENT ASSETS (LIABILITIES)			29,509		28,276

TOTAL ASSETS LESS CURRENT LIABILITIES			29,509		28,276

NET ASSETS			29,509		28,276

CAPITAL AND RESERVES
Called up share capital	7		1		1
Income Statement			29,508		28,275

SHAREHOLDERS' FUNDS			29,509		28,276

For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Income Statement.

On behalf of the board

Dr James Millen

Director

29 September 2025

The notes on pages 2 to 3 form part of these financial statements.

1. General Information

Lifescience Advisors Limited is a private company, limited by shares. It is incorporated in England & Wales, under a registered number of 09358385 . The registered office is 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of consideration received or receivable, net of discounts and value added taxes,

and is earned from the rendering of pharmaceutical and biotechnological consultancy services.

2.3. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Computer Equipment

33% straight line

2.4. Financial Instruments

Basic financial instruments are recognised at amortised cost using the effective interest method.

2.5. Registrar Filing Requirements

The company has taken advantage of Companies Act 2006 section 444(1) and opted not to file the income statement, directors report, and notes to the financial statements relating to the income statement.

3. Average Number of Employees

The average number of employees, including directors, during the year was NIL (2023: NIL)

4. Tangible Assets

	Computer Equipment
	£
Cost
As at 1 January 2024	2,145

As at 31 December 2024	2,145

Depreciation
As at 1 January 2024	2,145

As at 31 December 2024	2,145

Net Book Value
As at 31 December 2024	-

As at 1 January 2024	-

5. Debtors

	2024	2023
	£	£
Due within one year
Other debtors	500	500

Page 2

Page 3

Lifescience Advisors Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 December 2024

6. Creditors: Amounts Falling Due Within One Year

	2024	2023
	£	£
Other creditors	46	759

7. Share Capital

	2024	2023
Allotted, called up and fully paid	£	£
1 Ordinary Shares of £ 1.00 each	1	1